Drugs & Medical Devices

BEXTRA

Bextra is a COX-2 inhibitor, marketed by Pharmacia Corporation and Pfizer.  Bextra was approved by the FDA on November 16, 2001, and hit the market shortly thereafter, promising the same painkilling benefits as other COX-2 inhibitors, Vioxx and Delebrex.  The drug is prescribed for the treatment of osteoarthritis, adult rheumatioid arthritis, and pain associated with menstrual cramping.

Following the Vioxx recall, Pfizer’s painkiller, Bextra, has been under scrutiny.   Research conducted at Wake Forest University School of Medicine, indicates that Pfizer is claiming Bextra is safe, but they are ignoring the fact that they have data showing harm in high-risk people. The FDA will be holding an advisory meeting in early 2005 to consider the safety issues of using the drug.

In 2003, Bextra accounted for $687 million in sales.  Yet recently, it has been linked to heart attack, stroke, and serious clots.  In a recent warning to healthcare professionals, Pfizer has warned that Bextra might increase the risk of cardiovascular events, including heart attack or stroke, especially in coronary bypass surgery patients.

Along with increased risks of heart attack or stroke, a new warning was recently issued on the Bextra label warning patients of the increased risk of Stevens-Johnson Syndrome, a serious skin reaction that can possibly be fatal.  Symptoms of Stevens-Johnson syndrome include blistering of the mouth and lips, spreading to other parts of the body.  The blisters sometimes can become so extensive as to be fatal.

If you or a loved one has experienced a heart attack, stroke, or serious clot while taking Bextra (Valdecoxib), you may want to consider your potential legal claim for this loss.  If you would like Mark Davis, P.C. to evaluate your claim, contact us at 1-800-277-0300.   Our experienced staff will assist you with your claim.

VIOXX/CELEBREX/BEXTRA LINKS:

FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Withdraws the Product.

Bextra Effects on Heart Patients

Side effects of Vioxx.

The double edge sword of COX-2 NSAIDS.

Bextra information provided by FDA.

Consumer information regarding Celebrex.

Briefing Document for the FDA Advisory Committee prior to withdrawal of Vioxx.